← Back to all trials
Completed
NCT06837077
Study of SHR-1209 Administered by Single-site or Multiple-site Subcutaneous Injections in Healthy Volunteers
Conditions: Hypercholesterolemia and Hyperlipidemia
Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: Yes
Phase: PHASE1
Enrollment: 49
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Location: The First Affiliated Hospital of USTC Hefei Anhui
Summary
In order to improve the medication convenience and compliance of patients and facilitates in the long-term control of disease condition, it is planned to reduced the number of injections to one per administration. The study aims to compare the safety and pharmacokinetics data to assess feasibility of single-site and multiple-site injection for administration.
Eligibility Criteria
Inclusion Criteria:
1. Understanding the research procedures and methods, being able to complete the research in accordance with the procedure requirements, and sign the informed consent;
2. The age on the date of signing the informed consent must be ≥18 years old and ≤55 years old;
3. Body mass index (BMI) at screening period must be ≥19.0 kg/m2 and \
Source: ClinicalTrials.gov (NCT06837077). StuddyBuddy aggregates publicly available trial information.
